Announcements

New Impact Factor for Journal of Thoracic Disease: 2.046

Published: 2020-06-30

We are pleased to announce that the Journal of Thoracic Disease (JTD) has attained its latest impact factor update for the 2019 citation year: 2.046.

The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) is an international, peer-reviewed, open-access journal, which was founded in Dec 2009. JTD is indexed by Science Citation Index Expanded (SCIE), PubMed/PubMed Central, and Scopus. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), and monthly (Jan. 2014-). JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to the thoracic disease. All of the submission and reviewing processes are conducted electronically so that a rapid review process is assured.

Aiming for the continued development of article quality alongside the growth of the numbers of submissions, we have recently emphasized improving the publication quality and processing transparency. Some significant arrangements were made in JTD in the past few months:

1. Integration with Publons. As of April 2020, our publisher AME Publishing Company has entered into an official partnership with Publons. Thus, JTD’s peer review system is now integrated seamlessly into the Publons platform (https://publons.com/publisher/6041/ame-publishing-company). The partnership allows for the contributions of our expert peer-reviewers to be recognized anytime. For more information, see: http://jtd.amegroups.com/announcement/view/277.

2. Reporting guidelines for original research. For a higher standard of publishing and research quality, we have introduced a series of reporting guidelines for different research types. Each original research submission to JTD is now required to follow the EQUATOR research reporting guidelines and should include a checklist. If the article is accepted, the related reporting checklist will be published online with the article. For more details, please check the updated guidelines for authors: http://jtd.amegroups.com/pages/view/guidelines-for-authors.

3. Transparent peer review process. To commit to openness and accountability, and to increase the level of transparency throughout our peer review process, our Editorial Office has decided to implement a transparent peer review process as an option for all manuscripts submitted to JTD from April 22, 2020. Click here for further information: http://jtd.amegroups.com/announcement/view/269.

We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.

We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in thoracic disease to bring more exciting content to readers in the coming future.


Editorial Office
Journal of Thoracic Disease
June 30, 2020